Edwards Lifesciences Corporation (EW) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-09 (expected, after the close). EPS estimate 0.66, revenue estimate 1.71B.
Over the last 12 reports the stock moved 5.7% on average (either way), rising 7 times and falling 5. EPS beat estimates 10 of 12 times; revenue 10 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | 0.80 | 0.74 | +7.5% | 1.72B | 1.68B | +5.9% |
| Q2 FY2026 | 2026-07-23 | 0.78 | 0.74 | +5.0% | 1.74B | 1.70B | -2.1% |
| Q1 FY2026 | 2026-04-23 | 0.78 | 0.73 | +7.0% | 1.65B | 1.60B | +3.2% |
| Q4 FY2025 | 2026-02-10 | 0.58 | 0.62 | -6.1% | 1.57B | 1.55B | +3.3% |
| Q3 FY2025 | 2025-10-30 | 0.67 | 0.60 | +12.4% | 1.55B | 1.50B | -0.3% |
| Q2 FY2025 | 2025-07-24 | 0.67 | 0.62 | +7.4% | 1.53B | 1.49B | +4.0% |
| Q1 FY2025 | 2025-04-23 | 0.64 | 0.60 | +7.4% | 1.41B | 1.40B | +6.4% |
| Q4 FY2024 | 2025-02-11 | 0.59 | 0.55 | +7.1% | 1.39B | 1.36B | +6.6% |